Factual and citation issues
Incorrect statements, inaccurate citations, broken source links or misleading wording.
Accuracy and Accountability
GLP1Scientist Corrections Policy
How GLP1Scientist receives, assesses, prioritizes and publishes factual, citation, regulatory and data corrections.
What may be reported
Corrections can cover facts, sources, data and presentation
Regulatory and medicine issues
Outdated approvals, warnings, formulation details or product status.
Trial, patent and company issues
Incorrect clinical-trial, patent, ownership or company information.
Market and access issues
Outdated pricing, availability, market or access data.
Commercial transparency
Undisclosed commercial relationships or misleading paid placement.
Presentation and accessibility
Image, table, formatting or accessibility errors that affect usability or meaning.
Correction process
How a report is assessed
1. Record and locate
The affected URL, statement, table, image or section and supporting information are recorded.
2. Review the source
The original source and the precise context of the published claim are checked.
3. Check current evidence
Newer regulator, study, registry, company, patent or market sources are reviewed where relevant.
4. Classify and act
The issue is classified as an error, update, evolving evidence, interpretive disagreement, formatting issue or unsupported report.
Materiality
Minor, substantive and critical issues
Minor
Spelling, formatting, punctuation or non-substantive wording that does not change meaning.
Substantive
Incorrect facts, misleading comparisons, wrong approval status, inaccurate study results or materially outdated data.
Critical
Information capable of creating serious medical misunderstanding, false safety information, fabricated evidence or materially false regulatory status.
Priority rule: Critical issues receive priority. Submission does not guarantee that the requested change will be made; decisions depend on evidence, source quality, jurisdiction and material effect.